The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD

Lung

Volumn 194, Issue 6, 2016, Pages 889-895

  Al shair, Khaled ^a,b   Kolsum, Umme ^a   Singh, Dave ^a   Vestbo, Jørgen ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; C REACTIVE PROTEIN;

AGE; AGED; AIRWAY OBSTRUCTION; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD GAS; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; DYSPNEA; EXERCISE TOLERANCE; FAT FREE MASS; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HEART RATE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; OXYGEN SATURATION; PRIORITY JOURNAL; SMOKING; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; BLOOD; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; WALK TEST;

AGED; C-REACTIVE PROTEIN; DYSPNEA; EXERCISE TOLERANCE; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TUMOR NECROSIS FACTOR-ALPHA; WALK TEST;

EID: 84983499600     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-016-9931-y     Document Type: Article

References (48)

1. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187(4):347–365
2. Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R (2008) Are patients with COPD more active after pulmonary rehabilitation? Chest 134(2):273–280
3. Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory Questionnaire. Am Rev Respir Dis 145(6):1321–1327
4. Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J (2009) Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 103(10):1572–1579
5. Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PM, Pinto-Plata V et al (2010) Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort. Respir Med 104(6):849–857
6. Hanania NA, Mullerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF et al (2011) Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 183(5):604–611
7. Cote CG, Pinto-Plata V, Kasprzyk K, Dordelly LJ, Celli BR (2007) The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest 132(6):1778–1785
8. Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Jaime A et al (2008) Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 134(4):746–752
9. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A et al (2006) Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173(12):1326–1334
10. Kapella MC, Larson JL, Patel MK, Covey MK, Berry JK (2006) Subjective fatigue, influencing variables, and consequences in chronic obstructive pulmonary disease. Nurs Res 55(1):10–17
11. American Thoracic Society (2002) ATS Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117
12. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, Loukides S (2007) Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 132(1):164–169
13. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61(1):17–22
14. de Torres JP, Pinto-Plata V, Casanova C, Mullerova H, Cordoba-Lanus E, Muros de Fuentes M et al (2008) C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 133(6):1336–1343
15. Man WD, Soliman MG, Gearing J, Radford SG, Rafferty GF, Gray BJ et al (2003) Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168(5):562–567
16. Onorati P, Antonucci R, Valli G, Berton E, De Marco F, Serra P et al (2003) Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 89(3–4):331–336
17. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ (1992) Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 146(4):935–940
18. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778
19. Breslin E, van der Schans C, Breukink S, Meek P, Mercer K, Volz W et al (1998) Perception of fatigue and quality of life in patients with COPD. Chest 114:958–964
20. Paddison JS, Effing TW, Quinn S, Frith PA (2013) Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J 41(3):565–570
21. Al-Shair K, Muellerova H, Yorke J, Rennard SI, Wouters EF, Hanania NA et al (2012) Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes 10(1):100
22. Al-shair K, Muldoon EG, Morris J, Atherton GT, Kosmidis C, Denning DW (2016) Characterisation of fatigue and its substantial impact on health status in a large cohort of patients with chronic pulmonary aspergillosis (CPA). Respir Med 114:117–122
23. Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD (2009) Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med 103(7):1070–1075
24. Williams JE, Singh SJ, Sewell L, Morgan MD (2003) Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax 58(6):515–518
25. Baltzan MA, Scott AS, Wolkove N, Bailes S, Bernard S, Bourbeau J et al (2011) Fatigue in COPD: prevalence and effect on outcomes in pulmonary rehabilitation. Chron Respir Dis 8(2):119–128
26. Arslan S, Oztunc G (2015) The effects of a walking exercise program on fatigue in the person with COPD. Rehabil Nurs Off J Assoc Rehabil Nurs. doi:10.1002/rnj.206
27. Al-Shair K, Kolsum U, Berry P, Smith J, Caress A, Singh D et al (2009) Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale. Thorax 64(11):950–955
28. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54:581–586
29. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA et al (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350(10):1005–1012
30. Cote CG, Casanova C, Marin JM, Lopez MV, Pinto-Plata V, de Oca MM et al (2008) Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J 31(3):571–578
31. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
32. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF (1993) Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147:1151–1156
33. Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14(5):377–381
34. Ries AL (2005) Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2(1):105–110
35. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ et al (2008) Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 31(2):416–469
36. Miller MR, Crapo R, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry “ATS/ERS task force: standardisation of lung function testing”. Eur Resp J 26:319–338
37. Spiro SG, Dowdeswell IRG (1976) Arterialized ear lobe blood samples for blood gas tensions. Br J Dis Chest 70:263–268
38. Steiner MC, Singh SJ, Morgan MD (2005) The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 25(1):43–49
39. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 177(7):743–751
40. Scharf SM, Maimon N, Simon-Tuval T, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A (2011) Sleep quality predicts quality of life in chronic obstructive pulmonary disease. Int J Chron Obstr Pulm Dis 6:1–12
41. Calvert LD, Steiner MC, Morgan MD, Singh SJ (2010) Plasma ammonia response to incremental cycling and walking tests in COPD. Respir Med 104(5):675–681
42. Janson-Bjerklie S, Carrieri VK, Hudes M (1986) Thesensations of pulmonary dyspnea. Nurs Res 35:154–159
43. Baghai-Ravary R, Quint JK, Goldring JJ, Hurst JR, Donaldson GC, Wedzicha JA (2009) Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 103(2):216–223
44. Al-Shair K, Müllerova H, Locantore N, Hanania NA, Sharafkhaneh A, Wouters E et al (2011) Fatigue in COPD is significantly associated with exacerbations; data from the ECLIPSE cohort study. Am J Respir Crit Care Med 183:A3974
45. Gift AG, Pugh LC (1993) Dyspnea and fatigue. Nurs Clin North Am 28(2):373–384
46. Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J (2011) Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 12:3
47. Spruit MA, Pennings HJ, Janssen PP, Does JD, Scroyen S, Akkermans MA et al (2007) Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade. Respir Med 101(12):2454–2463
48. Garrod R, Marshall J, Barley E, Jones PW (2006) Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 27(4):788–794